Business Context and Reporting Period
This Form 8-K Current Report was filed by Illumina, Inc. on February 22, 2010. The report discloses a material event regarding the departure of a senior executive officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation and departure terms.
Material Changes
The primary material change reported is the resignation of Joel McComb, Senior Vice President & General Manager, Life Sciences. His resignation is effective February 28, 2010, to pursue other professional opportunities.
Management Commentary and Unusual Items
In connection with Mr. McComb's resignation, the Company entered into a Severance and Release Agreement. Provided Mr. McComb does not revoke acceptance by March 2, 2010, the agreement includes:
- A severance payment of $259,544.08, subject to tax withholdings.
- Limited acceleration of the vesting period for outstanding stock options.
- Limited extension of the exercise period for certain vested stock options.
- A customary release of any and all claims against the Company.
Investor Verification Checklist
- Confirm the effective date of the executive departure (February 28, 2010).
- Verify the total cash severance obligation ($259,544.08).
- Review the specific terms regarding stock option acceleration and extension in the full Severance and Release Agreement.
- Monitor for any subsequent filings regarding the appointment of a replacement for the Life Sciences division.